Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin.
Pooled human immunoglobulin suitable for intravenous administration (IGIV) was evaluated in the prophylaxis and treatment of herpes simplex virus (HSV) type 1 encephalitis in a murine model. Four-week-old BALB/c mice received a single intraperitoneal injection of IGIV or saline 24 h before or up to...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1987
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174861/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821882/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.7.1006 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|